Here, we analyzed broadly neutralizing antibodies isolated from long-term hospitalized convalescent patients of early SARS-CoV-2 strains. Antibodies named NCV2SG48 and NCV2SG53 are highly potent to broad SARS-CoV-2 variants. To reveal the mode of action, we determined the crystal structure of the Fab fragment of NCV2SG48 or NCV2SG53 in a complex with RBD of the S proteins from the Wuhan-Hu-1 and Omicron BA.1.
No takes yet. Share an insight, caveat, or question.
Higashiura et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: